Earn points on every order New products in stock Free 51-page beginner’s guide
← Back to Compound Library

Ventfort

Circulation and vascular support. Ventfort is a vascular-tissue extract commonly included in oral healthy-ageing stacks.

Research referenceCommunity compiled

Molecular profile

What this material is, and why it has no fixed molecular structure.

Class
Natural peptide complex (Cytomax A-3)
Receptor / pathway
Vascular tissue peptides

About this compound

A tissue-derived peptide complex, not a single molecule. Molecular weight varies by batch and no fixed sequence or formula applies.

Classification from the Cytomax product literature. No sequence or formula is published because none exists for a complex.
Research & reference information

This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.

Overview

Ventfort is a natural peptide bioregulator extracted from young animal blood vessels, containing vascular-specific peptide fractions.

What problem it targets: It targets arterial stiffness, atherosclerosis, poor peripheral circulation, cold hands and feet, high blood pressure, and vascular aging.

What It Does

• Rebuilds vascular endothelial integrity: Delivers vascular signaling peptides directly to blood vessel walls, stimulating collagen and elastin repair in arteries and veins.

• Restores arterial elasticity and compliance: Reverses age-related stiffening of arterial walls, allowing blood vessels to dilate and contract smoothly with blood pressure changes.

• Improves microcirculation to vital organs: Enhances capillary blood flow, ensuring oxygen and essential nutrients reach the brain, heart, skin, and extremities efficiently.

• Realistic expectations: Taken in 10- to 30-day courses. Promotes cardiovascular health, arterial pliability, and peripheral warmth across weeks of consistent use.

Reconstitution

Finished oral extract: no reconstitution. This profile describes the referenced capsule or sublingual product. A 20 mg dry vial sold under the same name needs its own ingredient identity and supplier preparation instructions.

Presentation

The referenced preparation is a finished tissue-extract supplement. Capsule content and total capsule weight are different; use the exact product label.

Protocol

Community protocols & cycle timing

PhaseFrequencyAmountNotes
Common community cycle pattern10–20 consecutive days; a few courses per year with months between coursesCompound- and formulation-specific; see rows belowA shared cycle duration does not establish one shared dose. Oral labels may specify 30-day initial courses or 10-day maintenance courses.

Product directions

PhaseFrequencyAmountNotes
Referenced 60-capsule listing1–2 times daily with meals1–2 capsules per intakeRetail directions; the listing suggests repeat courses after 3–6 months. This does not establish clinical efficacy.

About these protocols

The community rows describe reported experience, not a standard or recommended human regimen. Product-label rows apply to the cited formulation; cell and animal rows describe research models. Oral extracts are kept separate from synthetic peptide vials.

Handling & Stacking

Organ / tissue
Blood vessels / vascular tissue
Cycle pattern
  • Bioregulators are often discussed as short 10–20-day courses, repeated a few times a year with months between courses, rather than continuous daily use.
  • This describes a community cycle pattern, not one universal dose.
  • Some finished oral products instead specify a 30-day course or 10-day maintenance course.
Injection site / route
Not applicable to the referenced oral extract. Use the finished capsule or sublingual formulation as labelled.
Storage
  • The referenced capsule products are stored dry and protected from light, at +2°C to +25°C.
  • Use the expiry date on the actual pack.
  • Liquid products may have different storage and opened-container instructions.
Side effects
Sensitivity to animal-derived ingredients or excipients is possible. Reliable product-specific adverse-event frequencies are not available.
What to expect
Users seek circulation and vascular resilience. A warm sensation or energy change does not establish improved vascular function.
Pairs discussed
Cerluten, Svetinorm, Sigumir, Vladonix and Endoluten appear with Ventfort in commercial bundles. These are reported pairings, not demonstrated synergy.
Avoid / interactions
Interactions with blood-pressure medicines, anticoagulants and antiplatelet medicines are insufficiently characterised.
Approved treatment context
  • The named preparation is not established here as an approved treatment for its marketed goals.
  • Approved alternatives depend on the diagnosed condition and cannot be assigned from an organ label alone.

Safety & Patient Education

What remains uncertain
Effects alongside antihypertensives, antiplatelet drugs and anticoagulants are not well established. The reviewed capsule listing includes lactose.
Product-label restrictions
  • Referenced capsule labels list intolerance to ingredients, pregnancy and lactation as contraindications.
  • These are label statements; they do not prove safety in every other situation.
Identity check
Ventfort is an extract; Vesugen is the synthetic KED peptide. Evidence for one does not automatically establish the other.